1990年至2020年东亚地区视力丧失的患病率:规模和时间趋势。

IF 1.2 4区 医学 Q3 OPHTHALMOLOGY
Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators
{"title":"1990年至2020年东亚地区视力丧失的患病率:规模和时间趋势。","authors":"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators","doi":"10.1080/09286586.2025.2496186","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine the magnitude and temporal trends of the prevalence of blindness and vision impairment (VI) in East Asia from 1990 to 2020.</p><p><strong>Methods: </strong>A systematic review and meta-analysis of population-based studies was performed to estimate the prevalence and affected population of blindness (presenting visual acuity < 3/60 in the better eyes), moderate-to-severe vision impairment (MSVI; 3/60≤ presenting visual acuity < 6/18), mild VI (6/18≤ presenting visual acuity < 6/12) and near VI due to uncorrected presbyopia (presenting near vision <N6 or N8 at 40 cm) for 1990, 2000, 2010 and 2020. A total of 74 studies were included.</p><p><strong>Results: </strong>In 2020, East Asia's age-standardized prevalence of blindness, MSVI, mild VI and near VI due to uncorrected presbyopia was 0.47% (95% uncertainty interval [UI], 0.41% to 0.52%), 2.77% (95% UI, 2.49% to 3.07%), 3.41% (95% UI, 3.06% to 3.78%), 7.38% (95% UI, 5.32% to 9.70%), with a higher prevalence in females compared to males. East Asians had lower prevalence of blindness and MSVI than the world population. Despite the decrease (27.7% for males and 27.1% for females) in age-standardized blindness prevalence in East Asia, the number of people with blindness and MSVI has increased from 7.0 to 9.1 million and 30.8 to 53.9 million from 2000 to 2020.</p><p><strong>Conclusions: </strong>While age-standardized blindness rates have declined in the past two decades, yet the number of people affected by blindness and MSVI continues to rise, indicating unmet eye care demands in East Asia amid population growth and aging.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-9"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Vision Loss in East Asia from 1990 to 2020: Magnitude and Temporal Trends.\",\"authors\":\"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators\",\"doi\":\"10.1080/09286586.2025.2496186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To determine the magnitude and temporal trends of the prevalence of blindness and vision impairment (VI) in East Asia from 1990 to 2020.</p><p><strong>Methods: </strong>A systematic review and meta-analysis of population-based studies was performed to estimate the prevalence and affected population of blindness (presenting visual acuity < 3/60 in the better eyes), moderate-to-severe vision impairment (MSVI; 3/60≤ presenting visual acuity < 6/18), mild VI (6/18≤ presenting visual acuity < 6/12) and near VI due to uncorrected presbyopia (presenting near vision <N6 or N8 at 40 cm) for 1990, 2000, 2010 and 2020. A total of 74 studies were included.</p><p><strong>Results: </strong>In 2020, East Asia's age-standardized prevalence of blindness, MSVI, mild VI and near VI due to uncorrected presbyopia was 0.47% (95% uncertainty interval [UI], 0.41% to 0.52%), 2.77% (95% UI, 2.49% to 3.07%), 3.41% (95% UI, 3.06% to 3.78%), 7.38% (95% UI, 5.32% to 9.70%), with a higher prevalence in females compared to males. East Asians had lower prevalence of blindness and MSVI than the world population. Despite the decrease (27.7% for males and 27.1% for females) in age-standardized blindness prevalence in East Asia, the number of people with blindness and MSVI has increased from 7.0 to 9.1 million and 30.8 to 53.9 million from 2000 to 2020.</p><p><strong>Conclusions: </strong>While age-standardized blindness rates have declined in the past two decades, yet the number of people affected by blindness and MSVI continues to rise, indicating unmet eye care demands in East Asia amid population growth and aging.</p>\",\"PeriodicalId\":19607,\"journal\":{\"name\":\"Ophthalmic epidemiology\",\"volume\":\" \",\"pages\":\"1-9\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09286586.2025.2496186\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2025.2496186","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:确定1990年至2020年东亚地区失明和视力障碍(VI)患病率的幅度和时间趋势。方法:对基于人群的研究进行系统回顾和荟萃分析,以估计失明(呈现视力)的患病率和受影响人群。2020年,东亚地区因未矫正老花导致的失明、MSVI、轻度VI和近VI的年龄标准化患病率分别为0.47%(95%不确定区间[UI], 0.41% ~ 0.52%)、2.77%(95%不确定区间[UI], 2.49% ~ 3.07%)、3.41% (95% UI, 3.06% ~ 3.78%)、7.38% (95% UI, 5.32% ~ 9.70%),女性患病率高于男性。东亚人的失明和MSVI患病率低于世界人口。尽管东亚的年龄标准化失明患病率下降了(男性为27.7%,女性为27.1%),但从2000年到2020年,失明和MSVI患者的人数从700万增加到910万,从3080万增加到5390万。结论:虽然年龄标准化失明率在过去二十年中有所下降,但受失明和MSVI影响的人数仍在上升,这表明在人口增长和老龄化的背景下,东亚地区的眼科保健需求未得到满足。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prevalence of Vision Loss in East Asia from 1990 to 2020: Magnitude and Temporal Trends.

Purpose: To determine the magnitude and temporal trends of the prevalence of blindness and vision impairment (VI) in East Asia from 1990 to 2020.

Methods: A systematic review and meta-analysis of population-based studies was performed to estimate the prevalence and affected population of blindness (presenting visual acuity < 3/60 in the better eyes), moderate-to-severe vision impairment (MSVI; 3/60≤ presenting visual acuity < 6/18), mild VI (6/18≤ presenting visual acuity < 6/12) and near VI due to uncorrected presbyopia (presenting near vision

Results: In 2020, East Asia's age-standardized prevalence of blindness, MSVI, mild VI and near VI due to uncorrected presbyopia was 0.47% (95% uncertainty interval [UI], 0.41% to 0.52%), 2.77% (95% UI, 2.49% to 3.07%), 3.41% (95% UI, 3.06% to 3.78%), 7.38% (95% UI, 5.32% to 9.70%), with a higher prevalence in females compared to males. East Asians had lower prevalence of blindness and MSVI than the world population. Despite the decrease (27.7% for males and 27.1% for females) in age-standardized blindness prevalence in East Asia, the number of people with blindness and MSVI has increased from 7.0 to 9.1 million and 30.8 to 53.9 million from 2000 to 2020.

Conclusions: While age-standardized blindness rates have declined in the past two decades, yet the number of people affected by blindness and MSVI continues to rise, indicating unmet eye care demands in East Asia amid population growth and aging.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmic epidemiology
Ophthalmic epidemiology 医学-眼科学
CiteScore
3.70
自引率
5.60%
发文量
61
审稿时长
6-12 weeks
期刊介绍: Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信